论文部分内容阅读
目的:观察巴曲酶对突发性耳聋的临床疗效。方法:将70例突发性耳聋患者随机分为两组,对照组患者给予改善微循环、溶栓、扩容、营养神经、能量合剂、糖皮质激素等药物治疗及给予高压氧舱等常规方法治疗,治疗组在常规治疗基础上加用巴曲酶,比较两组疗效。结果:治疗组总有效率88.57%,对照组总有效率62.86%,两组之间有统计学差异(P<0.05)。结论:在常规治疗的基础上加用巴曲酶治疗突发性耳聋取得较好疗效,值得临床推广。
Objective: To observe the clinical effect of batroxobin on sudden deafness. Methods: Seventy patients with sudden deafness were randomly divided into two groups. Patients in the control group were treated with conventional methods such as microcirculation, thrombolysis, dilatation, nutrition nerves, energy mixture, glucocorticoid and other drugs. In the treatment group, batroxobin was added on the basis of routine treatment, and the curative effect was compared between the two groups. Results: The total effective rate was 88.57% in the treatment group and 62.86% in the control group, with statistical significance (P <0.05). Conclusion: Batroxobin is effective in treating sudden deafness on the basis of routine treatment, which is worthy of clinical promotion.